Using the Cancer Risk Management Model to evaluate the health and economic impacts of cytology compared with human papillomavirus DNA testing for primary cervical cancer screening in Canada

BACKGROUND: In Canada, discussion about changing from cytology to human papillomavirus (hpv) dna testing for primary screening in cervical cancer is ongoing. However, the Canadian Task Force on Preventive Health Care has not yet made a recommendation, concluding that the evidence is insufficient. ME...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Curr Oncol
Prif Awduron: Popadiuk, C., Gauvreau, C.L., Bhavsar, M., Nadeau, C., Asakawa, K., Flanagan, W.M., Wolfson, M.C., Coldman, A.J., Memon, S., Fitzgerald, N., Lacombe, J., Miller, A.B.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Multimed Inc. 2016
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4780581/
https://ncbi.nlm.nih.gov/pubmed/26985148
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.23.2991
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg